Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Diet quality and Gleason grade progression among localised prostate cancer patients on active surveillance.

Gregg JR, Zheng J, Lopez DS, Reichard C, Browman G, Chapin B, Kim J, Davis J, Daniel CR.

Br J Cancer. 2019 Feb;120(4):466-471. doi: 10.1038/s41416-019-0380-2. Epub 2019 Jan 25.

PMID:
30679782
2.

Coffee, Caffeine Metabolism Genotype and Disease Progression in Patients with Localized Prostate Cancer Managed with Active Surveillance.

Gregg JR, Lopez DS, Reichard C, Zheng J, Wu W, Ye Y, Chapin B, Kim J, Daniel CR, Davis J.

J Urol. 2019 Feb;201(2):308-314. doi: 10.1016/j.juro.2018.08.048.

PMID:
30179617
3.

Population-based study of grade progression in patients who harboured Gleason 3 + 3.

Sampurno F, Earnest A, Millar J, Frydenberg M, Murphy D, Delprado W, Evans S.

World J Urol. 2017 Nov;35(11):1689-1699. doi: 10.1007/s00345-017-2047-z. Epub 2017 May 12.

PMID:
28500489
4.

A negative confirmatory biopsy among men on active surveillance for prostate cancer does not protect them from histologic grade progression.

Wong LM, Alibhai SM, Trottier G, Timilshina N, Van der Kwast T, Zlotta A, Lawrentschuk N, Kulkarni G, Hamilton R, Ferrara S, Margel D, Trachtenberg J, Jewett MA, Toi A, Evans A, Fleshner NE, Finelli A.

Eur Urol. 2014 Sep;66(3):406-13. doi: 10.1016/j.eururo.2013.04.038. Epub 2013 May 2.

PMID:
23664820
5.

Obesity is associated with risk of progression for low-risk prostate cancers managed expectantly.

Bhindi B, Kulkarni GS, Finelli A, Alibhai SM, Hamilton RJ, Toi A, van der Kwast TH, Evans A, Hersey K, Jewett MA, Zlotta AR, Trachtenberg J, Fleshner NE.

Eur Urol. 2014 Nov;66(5):841-8. doi: 10.1016/j.eururo.2014.06.005. Epub 2014 Jun 18.

PMID:
24954793
6.

PSA failure following definitive treatment of prostate cancer having biopsy Gleason score 7 with tertiary grade 5.

Patel AA, Chen MH, Renshaw AA, D'Amico AV.

JAMA. 2007 Oct 3;298(13):1533-8.

PMID:
17911498
7.

Index-based dietary patterns and risk of esophageal and gastric cancer in a large cohort study.

Li WQ, Park Y, Wu JW, Ren JS, Goldstein AM, Taylor PR, Hollenbeck AR, Freedman ND, Abnet CC.

Clin Gastroenterol Hepatol. 2013 Sep;11(9):1130-1136.e2. doi: 10.1016/j.cgh.2013.03.023. Epub 2013 Apr 13. Erratum in: Clin Gastroenterol Hepatol. 2014 Mar;12(3):529.

8.

High-Quality Diets Associate With Reduced Risk of Colorectal Cancer: Analyses of Diet Quality Indexes in the Multiethnic Cohort.

Park SY, Boushey CJ, Wilkens LR, Haiman CA, Le Marchand L.

Gastroenterology. 2017 Aug;153(2):386-394.e2. doi: 10.1053/j.gastro.2017.04.004. Epub 2017 Apr 17.

9.

Meat, Fish, Poultry, and Egg Intake at Diagnosis and Risk of Prostate Cancer Progression.

Wilson KM, Mucci LA, Drake BF, Preston MA, Stampfer MJ, Giovannucci E, Kibel AS.

Cancer Prev Res (Phila). 2016 Dec;9(12):933-941. Epub 2016 Sep 20.

10.

Predictors of pathologic progression on biopsy among men on active surveillance for localized prostate cancer: the value of the pattern of surveillance biopsies.

Cary KC, Cowan JE, Sanford M, Shinohara K, Perez N, Chan JM, Meng MV, Carroll PR.

Eur Urol. 2014 Aug;66(2):337-42. doi: 10.1016/j.eururo.2013.08.060. Epub 2013 Sep 9.

PMID:
24035632
11.

Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): an open-label, randomised, phase 3 factorial trial.

Denham JW, Joseph D, Lamb DS, Spry NA, Duchesne G, Matthews J, Atkinson C, Tai KH, Christie D, Kenny L, Turner S, Gogna NK, Diamond T, Delahunt B, Oldmeadow C, Attia J, Steigler A.

Lancet Oncol. 2014 Sep;15(10):1076-89. doi: 10.1016/S1470-2045(14)70328-6. Epub 2014 Aug 14.

PMID:
25130995
12.

Changes in Overall Diet Quality in Relation to Survival in Postmenopausal Women with Breast Cancer: Results from the Women's Health Initiative.

Sun Y, Bao W, Liu B, Caan BJ, Lane DS, Millen AE, Simon MS, Thomson CA, Tinker LF, Van Horn LV, Vitolins MZ, Snetselaar LG.

J Acad Nutr Diet. 2018 Oct;118(10):1855-1863.e6. doi: 10.1016/j.jand.2018.03.017. Epub 2018 May 30.

PMID:
29859758
13.

New Prostate Cancer Grading System Predicts Long-term Survival Following Surgery for Gleason Score 8-10 Prostate Cancer.

Ham WS, Chalfin HJ, Feng Z, Trock BJ, Epstein JI, Cheung C, Humphreys E, Partin AW, Han M.

Eur Urol. 2017 Jun;71(6):907-912. doi: 10.1016/j.eururo.2016.11.006. Epub 2016 Nov 19.

PMID:
27876305
14.

Index-based dietary patterns and the risk of prostate cancer in the NIH-AARP diet and health study.

Bosire C, Stampfer MJ, Subar AF, Park Y, Kirkpatrick SI, Chiuve SE, Hollenbeck AR, Reedy J.

Am J Epidemiol. 2013 Mar 15;177(6):504-13. doi: 10.1093/aje/kws261. Epub 2013 Feb 13.

15.

Dietary inflammatory index and prostate cancer survival.

Zucchetto A, Gini A, Shivappa N, Hébert JR, Stocco C, Dal Maso L, Birri S, Serraino D, Polesel J.

Int J Cancer. 2016 Dec 1;139(11):2398-404. doi: 10.1002/ijc.30208. Epub 2016 Jun 11.

16.

Diet quality is associated with reduced incidence of cancer and self-reported chronic disease: Observations from Alberta's Tomorrow Project.

Solbak NM, Xu JY, Vena JE, Csizmadi I, Whelan HK, Robson PJ.

Prev Med. 2017 Aug;101:178-187. doi: 10.1016/j.ypmed.2017.06.009. Epub 2017 Jun 7.

17.

Gleason Pattern 5 prostate cancer: further stratification of patients with high-risk disease and implications for future randomized trials.

Nanda A, Chen MH, Renshaw AA, D'Amico AV.

Int J Radiat Oncol Biol Phys. 2009 Aug 1;74(5):1419-23. doi: 10.1016/j.ijrobp.2008.10.027. Epub 2009 Jan 7.

PMID:
19131185
18.

Use of serial multiparametric magnetic resonance imaging in the management of patients with prostate cancer on active surveillance.

Walton Diaz A, Shakir NA, George AK, Rais-Bahrami S, Turkbey B, Rothwax JT, Stamatakis L, Hong CW, Siddiqui MM, Okoro C, Raskolnikov D, Su D, Shih J, Han H, Parnes HL, Merino MJ, Simon RM, Wood BJ, Choyke PL, Pinto PA.

Urol Oncol. 2015 May;33(5):202.e1-202.e7. doi: 10.1016/j.urolonc.2015.01.023. Epub 2015 Mar 6.

PMID:
25754621
19.
20.

Compliance Rates with the Prostate Cancer Research International Active Surveillance (PRIAS) Protocol and Disease Reclassification in Noncompliers.

Bokhorst LP, Alberts AR, Rannikko A, Valdagni R, Pickles T, Kakehi Y, Bangma CH, Roobol MJ; PRIAS study group.

Eur Urol. 2015 Nov;68(5):814-21. doi: 10.1016/j.eururo.2015.06.012. Epub 2015 Jun 29.

PMID:
26138043

Supplemental Content

Support Center